Key Events This Week
15 Jun: Stock opens at Rs.3,119.95, gains 4.11% amid positive volume
16 Jun: Downgrade to Sell rating by MarketsMOJO; technical indicators turn bearish
17 Jun: Mild bullish technical momentum despite broader bearish trend
18 Jun: Technical downgrade reinforces bearish momentum; stock dips marginally
19 Jun: Stock closes at Rs.3,346.95, up 1.84%, with mixed technical signals
15 June 2026: Strong Weekly Opening with 4.11% Gain
Sanofi India Ltd began the week on a positive note, closing at Rs.3,248.05, up 4.11% from the previous Friday’s close of Rs.3,119.95. The stock’s volume was robust at 5,401 shares, reflecting investor interest. This gain outpaced the Sensex’s 1.19% rise to 35,764.67, signalling early outperformance. The intraday range of Rs.3,194.35 to Rs.3,308.10 indicated some volatility but overall bullish sentiment.
16 June 2026: Downgrade to Sell Amid Weak Financials and Bearish Technicals
On 16 June, Sanofi India was downgraded from a Hold to a Sell rating by MarketsMOJO, citing deteriorating fundamentals and a shift to bearish technical indicators. Despite this, the stock closed higher at Rs.3,306.10, a 1.79% gain, though the technical outlook worsened. The Mojo Score stood at 47.0, reflecting cautious sentiment. The Sensex also advanced by 0.49% to 35,939.94, but Sanofi’s technical parameters, including daily moving averages and Bollinger Bands, turned more negative, signalling increased downside risk.
Crushing the market! This Small Cap from Aerospace & Defense just earned its spot in our Top 1% with impressive gains. Don't let this opportunity slip through your hands.
- - Recent Top 1% qualifier
- - Impressive market performance
- - Sector leader
17 June 2026: Mild Bullish Momentum Amidst Broader Bearishness
The stock showed resilience on 17 June, edging up 1.79% to close at Rs.3,303.85 despite a subtle shift from bearish to mildly bearish technical momentum. The intraday range of Rs.3,249.60 to Rs.3,335.00 reflected moderate volatility. Weekly MACD and KST indicators suggested some short-term positive momentum, though monthly MACD remained bearish. The Sensex gained 0.52% to 36,125.82, with Sanofi marginally underperforming on the day but maintaining outperformance for the week.
18 June 2026: Technical Downgrade Reinforces Bearish Momentum
On 18 June, Sanofi India’s technical indicators deteriorated further, with the Mojo Grade firmly at Sell and a Mojo Score of 47.0. The stock closed slightly down at Rs.3,364.75, a 0.07% decline from the previous day, amid subdued volume of 2,167 shares. Daily moving averages remained bearish, and Bollinger Bands indicated mild downward pressure. The Sensex rose 0.44% to 36,284.69, highlighting Sanofi’s relative weakness despite a modest weekly gain.
Considering Sanofi India Ltd? Wait! SwitchER has found potentially better options in and beyond. Compare this small-cap with top-rated alternatives now!
- - Better options discovered
- - + beyond scope
- - Top-rated alternatives ready
19 June 2026: Mixed Technical Signals Amid Mild Gain
Sanofi India closed the week at Rs.3,346.95, down 0.53% from the previous day’s close but up 1.84% intraday, reflecting mixed technical momentum. The stock traded between Rs.3,303.90 and Rs.3,380.00, showing moderate volatility. Weekly MACD and KST indicators remained mildly bullish, while monthly counterparts stayed bearish. The Relative Strength Index (RSI) was neutral, and Bollinger Bands suggested mild bearishness. The Sensex declined 0.30% to 36,174.54, with Sanofi outperforming on the week overall.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-06-15 | Rs.3,248.05 | +4.11% | 35,764.67 | +1.19% |
| 2026-06-16 | Rs.3,306.10 | +1.79% | 35,939.94 | +0.49% |
| 2026-06-17 | Rs.3,303.85 | -0.07% | 36,125.82 | +0.52% |
| 2026-06-18 | Rs.3,364.75 | +1.84% | 36,284.69 | +0.44% |
| 2026-06-19 | Rs.3,346.95 | -0.53% | 36,174.54 | -0.30% |
Key Takeaways from the Week
1. Outperformance Despite Downgrade: Sanofi India outpaced the Sensex with a 7.28% weekly gain versus 2.35%, even as MarketsMOJO downgraded the stock to Sell citing weak financials and bearish technicals.
2. Mixed Technical Signals: Weekly MACD and KST oscillators showed mild bullishness, suggesting short-term resilience, but monthly indicators and daily moving averages remained bearish, indicating persistent downward pressure.
3. Weak Financial Trends: The downgrade reflected declining sales and profitability, with a 46.93% share price drop over the past year contrasting sharply with the Sensex’s 5.98% gain.
4. Volatility and Range Bound Trading: The stock traded within a wide 52-week range of Rs.3,057.60 to Rs.6,399.95, with recent price action closer to the lower end, highlighting ongoing uncertainty.
5. Institutional Holding and Market Cap: Despite challenges, Sanofi India maintains a 26.77% institutional holding and is classified as a small-cap stock, factors that contribute to its volatility and risk profile.
Overall, the week was characterised by cautious optimism amid fundamental and technical headwinds. The stock’s ability to outperform the Sensex despite a Sell rating and bearish technicals suggests some underlying support, but longer-term challenges remain significant.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
